Home / Products / Cancer (Tumor) Cell Lines / KM12-SM
KM12-SM
Datasheet Protocol

KM12-SM

Cat. No. ARC0402
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Large intestine (colon)

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

KM12-SM is a cancer cell line of large intestine (colon) carcinoma from Homo sapiens (Human).
 
Synonym: KM12SM; KM12 SM

Recommended Products

ENOPH1 Knockout NCI-H1299 Polyclonal Cells ENOPH1 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG17888 KCNJ15 Knockout HAP1 Polyclonal Cells KCNJ15 Knockout HAP1 Polyclonal Cells Cat. No. ARG22943 C1RL Knockout AGS Polyclonal Cells C1RL Knockout AGS Polyclonal Cells Cat. No. ARG26798 FAM98C Knockout MES-OV Polyclonal Cells FAM98C Knockout MES-OV Polyclonal Cells Cat. No. ARG6416 COL5A1 Knockout MES-OV Polyclonal Cells COL5A1 Knockout MES-OV Polyclonal Cells Cat. No. ARG6410 Immortalized Human Cardiac Microvascular Endothelial Cell Immortalized Human Cardiac Microvascular Endothelial Cell Cat. No. ARI0130
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Large intestine (colon)
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

KIF13B Knockout NCI-H1299 Polyclonal Cells

KIF13B Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30917
 BBC3 Knockout 143B Polyclonal Cells

BBC3 Knockout 143B Polyclonal Cells

Cat. No. ARG35072
 CCL19 Knockout HAP1 Polyclonal Cells

CCL19 Knockout HAP1 Polyclonal Cells

Cat. No. ARG43165
 C2CD5 Knockout HAP1 Polyclonal Cells

C2CD5 Knockout HAP1 Polyclonal Cells

Cat. No. ARG27448
 NUDT19 Knockout A549 Polyclonal Cells

NUDT19 Knockout A549 Polyclonal Cells

Cat. No. ARG9963
 GALNT2 Knockout AGS Polyclonal Cells

GALNT2 Knockout AGS Polyclonal Cells

Cat. No. ARG2589